APA (7th ed.) Citation

SY, P., CH, W., YJ, S., JP, C., HJ, L., IJ, W., & CC, C. (2026). Association of Tirzepatide versus Glucagon-Like Peptide-1 Receptor Agonists with Incident Glaucoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study. Ophthalmology science, 6(7), 101245. https://doi.org/10.1016/j.xops.2026.101245

Chicago Style (17th ed.) Citation

SY, Pan, Weng CH, Sheen YJ, Chen JP, Lin HJ, Wang IJ, and Chou CC. "Association of Tirzepatide Versus Glucagon-Like Peptide-1 Receptor Agonists with Incident Glaucoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study." Ophthalmology Science 6, no. 7 (2026): 101245. https://doi.org/10.1016/j.xops.2026.101245.

MLA (9th ed.) Citation

SY, Pan, et al. "Association of Tirzepatide Versus Glucagon-Like Peptide-1 Receptor Agonists with Incident Glaucoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study." Ophthalmology Science, vol. 6, no. 7, 2026, p. 101245, https://doi.org/10.1016/j.xops.2026.101245.